IFNA1 and COVID-19: (3) In blood immune cells of patients with COVID-19, the IFN release activates mitochondrial IFI27 and destroys mitochondrial energy metabolism in T and B cells, thereby promoting the plasma cell differentiation and lung–blood shuttle of Tregs, and eventually leading to cytokine storm and excessive inflammation (Figure 7).